Drugmakers Turn to AI for Drug Development Amid US Tariff Uncertainty Pharmaceutical executives are increasingly turning to artificial intelligence (AI) to revolutionize the drug development process. In a recent industry gathering, these leaders delved into the promising role of AI in expediting research, enhancing clinical trials, and ultimately bringing life-saving medications to market more efficiently. […]